tipo
- journal article
Correspondence on `Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial?
Documento
- Visão geral
- Pesquisas
- Identidade
- Informação adicional documento
- Outro
- Ver todos